Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) Sees Large Increase in Short Interest

Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEPW) was the recipient of a large growth in short interest during the month of February. As of February 27th, there was short interest totaling 7,403 shares, a growth of 1,991.2% from the February 12th total of 354 shares. Based on an average daily volume of 8,290 shares, the days-to-cover ratio is currently 0.9 days. Based on an average daily volume of 8,290 shares, the days-to-cover ratio is currently 0.9 days.

Coeptis Therapeutics Price Performance

NASDAQ:COEPW opened at $0.01 on Wednesday. Coeptis Therapeutics has a twelve month low of $0.00 and a twelve month high of $0.05. The company’s 50 day moving average is $0.01 and its two-hundred day moving average is $0.02.

Coeptis Therapeutics Company Profile

Coeptis Therapeutics is a clinical‐stage biopharmaceutical company focused on developing novel therapies for neurodegenerative and neuroinflammatory disorders. The company’s proprietary platform is based on engineered analogs of small heat shock proteins designed to modulate cellular stress responses, reduce inflammation and protect neurons from degeneration. Coeptis’s lead program is being advanced in amyotrophic lateral sclerosis (ALS), with additional preclinical studies underway in conditions such as multiple sclerosis and other central nervous system diseases.

Using its heat shock protein analog technology, Coeptis seeks to address the underlying pathology of neurodegeneration rather than merely managing symptoms.